Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine hydrochloride sustained-release tablets for ADHD in children and adolescents
CTR20221369Phase 3Completed
- Sponsor
- Shandong Dain Marine Biopharmaceutical
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clonidine in attention deficit hyperactivity disorder (ADHD), sponsored by Shandong Dain Marine Biopharmaceutical. Started Jun 2022; status: completed.
02
Drugs
clonidine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on CTR20221369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221369.